Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SUZ12 contributors: mct - updated : 29-04-2016
HGNC name suppressor of zeste 12 homolog (Drosophila)
HGNC id 17101
DNA
TYPE functioning gene
STRUCTURE 64.01 kb     16 Exon(s)
MAPPING cloned Y linked N status provisional
regionally located NF1 region, gross deletion
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
16 - 4477 - 739 - 2002 12435631
EXPRESSION
Type ubiquitous
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Endocrinepancreas    
Hearing/Equilibriumearinnercochlea highly
Lymphoid/Immunelymph node   highly
Nervousbrainlimbic systemhippocampus  
 brainhindbraincerebellumcerebellar cortexhighly
Urinarykidney    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
 bone marrow  highly
cells
SystemCellPubmedSpeciesStageRna symbol
NervousPurkinje cell
Nervouspyramidal cell
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period fetal
Text pancreas
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • C terminal zinc finger domain
  • HOMOLOGY
    interspecies homolog to drosophila Suz12
    Homologene
    FAMILY
  • VEFS (VRN2-EMF2-FIS2-SU(Z)12) family
  • CATEGORY unknown/unspecified
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • polycomb group protein mediating mitotic recombination causing somatic mosaicism in NF1
  • is required for active methyltransferase activity, Hox gene silencing, and embryonic stem cell differentiation
  • strong suppressor of position effect variegation
  • playing a necessary role for trimethylation of histone H3 on lysine 27 (H3K27me3) on facultative heterochromatin, and regulating H3-K9 methylation in an EZH2-independent fashion
  • playing a role in constitutive heterochromatin formation
  • silences CEBPD promoter activity, enhancing the methylation of exogenous CEBPD promoter through the proximal CpG islands
  • both EED and SUZ12 are required for the integrity of PRC2 and PRC2-mediated H3K27 methylation
  • promotes the proliferation of human epithelial ovarian cancer cells by inhibiting apoptosis
  • EZH1 and SUZ12 act as positive regulators for NFKB1 signaling, demonstrating that EZH1, SUZ12 and UXT work synergistically to regulate pathway activation in the nucleus
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • part of EED/EZH2 histone methyltransferase complexes
  • component of the polycomb repressive complex 2 (PRC2)
  • part of PRC2 complex containing four core components: EZH2, EED, SUZ12, and RBBP7
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • . interacting with SNAI1 (SNAI1 increases the binding of SUZ12 to the CDH1 promoter and the trimethylation of lysine 27 in histone H3)
  • Yin-Yang-1 (YY1) physically interacts with SUZ12 and can act as a mediator to recruit the polycomb group proteins and DNA methyltransferases to participate in the CEBPD gene silencing process
  • putative target of the WNT noncanonical signaling pathway
  • interacts with EED, EZH2 and RBBP4 to form the polycomb repressive complex 2 (PRC2), which functions to initiate epigenetic silencing of genes involved in cell fate decisions
  • positive correlation between expression of SUZ12 and EZH2
  • HRK is a novel SUZ12 target gene whose upregulation contributes to apoptosis induced by SUZ12 knockdown
  • directly binds to the promoters of the PRC2 target genes probably through its Zinc-finger domains
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) NF1DEL , IMMAS
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral   translocation    
    with JAZF1 in t(7;17) (p15;q21) in endometrial stromal sarcoma
    tumoral     --over  
    in bone marrow samples of patients at the blastic phase of chronic myeloid leukemia
    tumoral     --over  
    in epithelial ovarian cancer
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS